These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2918961)

  • 21. Erythropoietin and hypertension.
    Nowicki M
    J Hum Hypertens; 1995 Feb; 9(2):81-8. PubMed ID: 7752179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indications and contraindications for recombinant human erythropoietin treatment. Results in hemodialysis patients.
    Samtleben W; Baldamus CA; Bommer J; Grützmacher P; Nonnast-Daniel B; Scigalla P; Gurland HJ
    Contrib Nephrol; 1989; 76():193-200; discussion 212-8. PubMed ID: 2684521
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 24. Seizures in dialysis patients treated with recombinant erythropoietin. Review of the literature and guidelines for prevention.
    Beccari M
    Int J Artif Organs; 1994 Jan; 17(1):5-13. PubMed ID: 8188400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
    Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
    Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cerebrovascular incidents in 4 hemodialysis patients treated with erythropoietin].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1988 Oct; 118(40):1423-6. PubMed ID: 3187475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Fernández A; Vega N; Jiménez F; Macía M; Laraudiogoitía E; Hortal L; Perdomo M; Plaza C; Rodríguez JC; Palop L
    Am J Nephrol; 1992; 12(4):207-11. PubMed ID: 1481867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of endothelin in erythropoietin-induced hypertension in rats.
    Tsukahara H; Hori C; Tsuchida S; Hiraoka M; Fujisawa K; Mayumi M
    Nephron; 1998 Aug; 79(4):499-500. PubMed ID: 9689180
    [No Abstract]   [Full Text] [Related]  

  • 29. The treatment of anemia with low-dose recombinant human erythropoietin.
    Aronoff GR; Duff DR; Sloan RS; Brier ME; Maurice B; Erickson B; Golper TA
    Am J Nephrol; 1990; 10 Suppl 2():40-3. PubMed ID: 2260617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin use in peritoneal dialysis patients.
    Zimmerman SW; Johnson CA
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and blood rheologic stability in erythropoietin-treated predialysis patients.
    Brown CD; Friedman EA
    Am J Nephrol; 1990; 10 Suppl 2():29-33. PubMed ID: 2260615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin treatment does not compromise cardiovascular function in chronic renal failure.
    Haedersdal C; Mehlsen J; Stenver D; Nielsen B; Jeppesen L; Winther K
    Angiology; 1994 Mar; 45(3):231-4. PubMed ID: 8129205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term echocardiographic examinations in chronic hemodialysis patients substituted with recombinant human erythropoietin.
    Löw-Friedrich I; Grützmacher P; März W; Bergmann M; Schoeppe W
    Blood Purif; 1990; 8(5):272-8. PubMed ID: 2151114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of recombinant human erythropoietin on hemodynamics in chronic hemodialysis patients].
    Tomura S
    Nihon Rinsho; 1991 Dec; 49 Suppl():695-701. PubMed ID: 1808338
    [No Abstract]   [Full Text] [Related]  

  • 35. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y; Ito K
    Adv Perit Dial; 1992; 8():448-52. PubMed ID: 1361845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of erythropoietin on the dialysis prescription.
    Van Wyck DB
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):71-5. PubMed ID: 1928083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the intracellular calcium-mediated pathway involved in erythropoietin-induced hypertension?
    Morikawa K; Kuroda M; Hasegawa T
    Nephron; 1993; 65(3):503-4. PubMed ID: 8290018
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of recombinant human erythropoietin (r-Hu EPO) therapy on blood pressure in dialysis patients.
    Ksiazek A
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():23-8. PubMed ID: 8192529
    [No Abstract]   [Full Text] [Related]  

  • 39. [The after effect of r-HuEPO in treating anemic hemodialysis patients].
    Chu JQ
    Zhonghua Hu Li Za Zhi; 1994 Feb; 29(2):78-9. PubMed ID: 7788758
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of hypertension after different treatments of anaemia in haemodialysis patients.
    Teruel JL; Pascual J; Otero GG; Ortuño J
    Nephrol Dial Transplant; 1992; 7(7):652. PubMed ID: 1323079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.